Transthyretin Amyloid CardiomyopathySymptoms, Doctors, Treatments, Advances & More
Transthyretin Amyloid Cardiomyopathy Overview
Learn About Transthyretin Amyloid Cardiomyopathy
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Cleveland Clinic Main Campus
Mazen Hanna is a Cardiologist practicing medicine in Cleveland, Ohio. He has been practicing medicine for over 33 years. Dr. Hanna is rated as an Elite provider by MediFind in the treatment of Transthyretin Amyloid Cardiomyopathy. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Cardiac Amyloidosis, Transthyretin Amyloid Cardiomyopathy, Primary Amyloidosis, Heart Transplant, and Tenotomy.
Boston Medical Center Outpatient Pharmacy
Frederick Ruberg is a Cardiologist practicing medicine in Boston, Massachusetts. Dr. Ruberg is rated as an Elite provider by MediFind in the treatment of Transthyretin Amyloid Cardiomyopathy. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Primary Amyloidosis, Cardiac Amyloidosis, Transthyretin Amyloid Cardiomyopathy, Heart Transplant, and Cardiac Ablation.
Brigham And Women's Hospital
Rodney Falk is a Cardiologist practicing medicine in Boston,, Massachusetts. Dr. Falk is rated as an Elite provider by MediFind in the treatment of Transthyretin Amyloid Cardiomyopathy. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Cardiac Amyloidosis, Primary Amyloidosis, Transthyretin Amyloidosis, Heart Transplant, and Cardiac Ablation.
Summary: The purpose of this randomised, double-blind, placebo-controlled, multicenter study is to evaluate the efficacy and safety of concomitant use of eplontersen and ALXN2220 compared with eplontersen and placebo in adult participants with Transthyretin-mediated amyloid cardiomyopathy (ATTR-CM).
Summary: Transthyretin (TTR) is a protein made by the liver that helps transport thyroid hormone and vitamin A in the blood. In some people, this protein breaks down and forms harmful clumps called amyloid. TTR amyloid gets deposited in the heart wall and stops it from pumping blood properly, which may lead to heart failure. The breakage in TTR protein can be age-related (wild-type ATTR-CM), or genetic (va...


